Amazon expands Amazon Pharmacy GLP-1 delivery to eligible Medicare patients for $50 a month

Amazon said it is extending Amazon Pharmacy to deliver GLP-1 medications to eligible Medicare patients for a flat $50 per month, positioning the program around simplified paperwork and faster access. The company’s announcement follows the rapid mainstreaming of GLP-1 weight-loss and diabetes medicines, which have faced uneven availability and insurance hurdles for many patients.

Under the plan described by Amazon, eligible Medicare Part D patients can obtain GLP-1 drugs such as Wegovy, Zepbound and Foundayo through Amazon Pharmacy. The pricing is $50 per month, and Amazon says delivery is free to patients’ homes, with additional options for pickup at certain locations. Amazon also said Prime membership is not required for same-day delivery.

Amazon Pharmacy is built to handle key administrative steps that commonly slow prescription fulfillment. The company said it automates eligibility verification, prior authorization and billing, and that patients primarily need to add their Bridge insurance plan and Medicare ID to get started. Amazon did not detail whether all steps are completed electronically without a clinician or whether exceptions apply, but it emphasized the end-to-end processing inside the service.

On logistics, Amazon said same-day delivery is available in more than 3,100 U.S. cities and towns. It also said same-day delivery will expand to nearly 4,500 by the end of 2026, suggesting a staged roll-out rather than a nationwide launch on day one.

For patients who prefer collecting prescriptions in person, Amazon said Amazon Pharmacy offers in-office kiosk pickup at select One Medical locations. Amazon noted that newly approved Wegovy and Foundayo GLP-1 oral pills are dispensed through these kiosks, tying the kiosk format to a broader product mix rather than limiting it to injectable medications.

Amazon also highlighted additional support features aimed at families and caregivers. It said the service includes caregiver support that allows a trusted individual to manage medications on behalf of a loved one through the caregiver’s own Amazon account, which could reduce friction for patients who rely on family members for logistics and communications.

The company linked the Medicare-focused program to its broader pharmacy and membership offerings. Amazon referenced Prime Rx, which it describes as a way for members to save up to 80 percent on medications, including Medicare beneficiaries. It also pointed to RxPass, a $5 monthly Prime add-on subscription that Amazon says provides access to 60 generic medications with free home delivery regardless of the number of prescriptions, at no additional cost. Amazon framed RxPass as a potential savings lever for customers managing multiple chronic conditions who could otherwise pay more out-of-pocket per medication.

From a business perspective, the expansion reflects Amazon’s effort to deepen its healthcare footprint beyond general merchandise and into regulated pharmacy workflows. By putting insurance checks, prior authorization, and delivery timing into a single patient-facing experience, Amazon is trying to reduce one of the main barriers in GLP-1 access: the administrative complexity that can delay treatment even when a prescription is written.

Still, several practical details remain unclear from Amazon’s announcement. The company did not specify eligibility rules beyond being an eligible Medicare Part D patient, did not publish the terms for coverage verification beyond the mention of Bridge and Medicare ID, and did not say how frequently prior authorization decisions result in delays or denials. It also did not provide a list of all participating pharmacies or clinicians, nor did it describe inventory or substitution policies if a GLP-1 medication is unavailable in a given area.

What to watch next is how quickly Amazon Pharmacy scales the same-day delivery footprint toward its stated near-4,500-city target, and whether additional One Medical locations will add kiosk pickup for GLP-1 prescriptions. Patients and clinicians may also look for more information on how Amazon’s automated prior authorization and billing processes handle edge cases, such as plan-specific exceptions or medications that require additional documentation.